Johnson & Johnson vaccine 66 percent effective, drops against South Africa variant | TheHill

Johnson & Johnson vaccine 66 percent effective, drops against South Africa variant | TheHill: A COVID-19 single-shot vaccine from Johnson & Johnson was 66 percent effective in preventing moderate or severe disease in a phase 3 clinical trial, a level of protection above the Food and Drug Administration's (FDA) minimum but lower than th